How is the Mounjaro tracker different from the Zepbound tracker?

Both products contain tirzepatide, but their labels cover different uses: Mounjaro type 2 diabetes, Zepbound weight reduction and sleep apnea. This page adds glucose and A1C fields; the Zepbound page centres on weight.

Can I log glucose readings?

Yes. Add the Blood glucose and A1C fields with one tap and enter readings yourself. The tracker charts them and never interprets them.

Does it suggest a Mounjaro dose?

No. The amount is always yours to enter from your prescription. The tracker doesn’t suggest amounts or changes.

Single-dose pen or KwikPen: how do I count them?

Single-dose pens or vials: unit “count” with automatic deduction on, so each logged injection removes one. KwikPens and multi-dose vials, which the label says hold four doses: deduction off, and adjust when you start a new one.

Is this site connected to Eli Lilly?

No. It isn’t affiliated with or endorsed by Eli Lilly and Company. Mounjaro® is a trademark of Eli Lilly and Company.

Mounjaro tracker

For Mounjaro® taken for type 2 diabetes: log each weekly injection, keep your own glucose and A1C readings next to it, and count your pens or vials.

Not affiliated with or endorsed by Novo Nordisk or Eli Lilly. Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S; Zepbound® and Mounjaro® are trademarks of Eli Lilly and Company. This page is a record-keeping tool. It doesn’t give dosing or medical advice; follow your prescriber and the product’s label.

Log a Mounjaro injection

Glucose and A1C readings

Your injection day

Pens and vials on hand

How stock changes. You enter how much you have. With “Take logged amounts off” on, each taken entry with the same name comes off the remaining amount when the units match: the same unit, or mg and mcg (1 mg = 1,000 mcg). IU and ml only come off items counted in IU or ml. An item counted in whole containers (count: single-dose pens or vials) loses one per taken entry. Stock never goes below 0, and editing or deleting an entry gives its amount back. Nothing here converts between a vial’s contents and a volume; for concentration math use the Peptide Library calculator.

No items yet.

Weeks at a glance

Everything here is the same record as the full tracker, stored in this browser only. Export or back it up from its Data tab.

What the Mounjaro label says

From the MOUNJARO prescribing information

Ingredient: tirzepatide, a GIP and GLP-1 receptor agonist.
Approved uses: with diet and exercise, improving glycemic control in adults and children 10 years and older with type 2 diabetes; and reducing the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk for them.
Injected under the skin once weekly, at any time of day.
Injection areas: abdomen or thigh, or the back of the upper arm when another person gives the injection; the label says to rotate the site with each dose.
Forms: single-dose pens, single-dose vials, multi-dose vials and single-patient-use KwikPens (the last two hold four doses each).

Source: MOUNJARO (tirzepatide) prescribing information, Eli Lilly and Company, DailyMed (version of August 27, 2026). Amounts and dose changes are deliberately left out; they’re for your prescriber and the full label.

How this page differs from the Zepbound tracker

Mounjaro and Zepbound share an ingredient and the same container types, but they are separate products with separate labels. This page is set up for diabetes records: glucose and A1C fields come first, and the calendar shows your injection weeks next to them. The Zepbound page is set up around weight.

Readings you enter yourself

Type readings from your meter or lab reports with their date. The chart shows the trend of what you entered; your care team explains what it means. Use the journal for anything else you notice.

Pen and vial records

Count single-dose pens or vials with automatic deduction on, so each logged injection removes one and deleting the entry puts it back. For four-dose KwikPens or multi-dose vials, switch deduction off and adjust when you open a new one.

For reminders and sync across devices, Peptide Library’s GLP-1 tracker is the next step.

Label sources

Label facts on this page come only from FDA-approved prescribing information, checked November 8, 2026.

MOUNJARO (tirzepatide) prescribing information, Eli Lilly and Company, DailyMed (version of August 27, 2026)

Questions

How is the Mounjaro tracker different from the Zepbound tracker?: Both products contain tirzepatide, but their labels cover different uses: Mounjaro type 2 diabetes, Zepbound weight reduction and sleep apnea. This page adds glucose and A1C fields; the Zepbound page centres on weight.
Can I log glucose readings?: Yes. Add the Blood glucose and A1C fields with one tap and enter readings yourself. The tracker charts them and never interprets them.
Does it suggest a Mounjaro dose?: No. The amount is always yours to enter from your prescription. The tracker doesn’t suggest amounts or changes.
Single-dose pen or KwikPen: how do I count them?: Single-dose pens or vials: unit “count” with automatic deduction on, so each logged injection removes one. KwikPens and multi-dose vials, which the label says hold four doses: deduction off, and adjust when you start a new one.
Is this site connected to Eli Lilly?: No. It isn’t affiliated with or endorsed by Eli Lilly and Company. Mounjaro® is a trademark of Eli Lilly and Company.